![Pick Either Johnson & Johnson Stock Or This Healthcare Company – Both Are Likely To Offer Similar Returns | Trefis Pick Either Johnson & Johnson Stock Or This Healthcare Company – Both Are Likely To Offer Similar Returns | Trefis](https://s3.amazonaws.com/wp-uploads-trefis/articles/wp-content/uploads/2022/09/09005349/Screenshot-2022-09-09-at-10.23.31-AM.png)
Pick Either Johnson & Johnson Stock Or This Healthcare Company – Both Are Likely To Offer Similar Returns | Trefis
![GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_101380_a53786a6-9ceb-48f2-8411-276c2e1b6478_0.png)
GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
![Johnson & Johnson: 8-9% Annual Total Return Potential Makes This Dividend Aristocrat A Hold (NYSE:JNJ) | Seeking Alpha Johnson & Johnson: 8-9% Annual Total Return Potential Makes This Dividend Aristocrat A Hold (NYSE:JNJ) | Seeking Alpha](https://static.seekingalpha.com/uploads/2019/7/6/saupload_Screenshot_2B_2528168_2529.png)
Johnson & Johnson: 8-9% Annual Total Return Potential Makes This Dividend Aristocrat A Hold (NYSE:JNJ) | Seeking Alpha
![Johnson & Johnson Versus Pfizer: Which One Is The Better Income Investment? (NYSE:JNJ) | Seeking Alpha Johnson & Johnson Versus Pfizer: Which One Is The Better Income Investment? (NYSE:JNJ) | Seeking Alpha](https://static.seekingalpha.com/uploads/2018/3/12/25069623-1520875106187435.png)